1-0_slider1

Extensive Early-Phase Development Experience

● 180 beds available at our Phase 1 clinical trial unit
● Over 600 Phase 1 studies performed
● Various study designs supported: FIH, SAD/MAD, PK/PD, and more

LEARN MORE

coronavirus COVID-19

Infectious Disease and Vaccines Capabilities

● WCCT has conducted over 80 studies in the area of Infections and Infectious Disease.
● WCCT clinical pharmacology unit supports the streamlined clinical development of new vaccines, delivery systems, treatments and antimicrobial agents in a timely, cost-effective manner.
● Partner with a leader that has a track record in infectious diseases.

LEARN MORE

1-0_slider4

Breadth and Depth in Phase 1-2a Ophthalmology Clinical Research

● Network of 30+ ophthalmology research sites across the U.S.
● Recruitment of patients with corneal disorders, retinal diseases, and glaucoma / ocular hypertension
● Ophthalmology-specialized staff in clinical operations and project management

LEARN MORE

Phase 1 CRO with the Clinical
Expertise to Fuel Your Study

As a Phase 1 CRO specialized in early clinical development, we offer clinical trial services, overnight observation capabilities at our clinical site, and regulatory support. We utilize a collaborative approach which centers on taking your product to the next stage of development. WCCT is focused in these key areas:

Ethnic Bridging

WCCT has conducted over 185 Asian Ethnic Bridging trials, enrolling Japanese, Chinese, Korean, Taiwanese, Vietnamese and other Asian ethnicities.

Tobacco, Nicotine, and Smoking

With state-of-the-art smoking facilities and in-house scientific and regulatory expertise, WCCT helps Sponsors fulfill PMTA requirements and supports the development of tobacco, nicotine, and electronic nicotine device systems (ENDS) product review applications.

Infectious Disease and Vaccines

Since our founding in 1998, WCCT has conducted over 80 studies in the area of Infections and Infectious Disease. Supported by expert scientific, medical, regulatory, and clinical staff, the WCCT clinical pharmacology unit supports the streamlined clinical development of  new vaccines, delivery systems, treatments and antimicrobial agents in a timely, cost-effective manner. Partner with a leader that has a track record in infectious diseases.

Ophthalmology

Due to our extensive early clinical development experience and emphasis on overnight confinement, WCCT delivers a comprehensive new level of data collection to early phase ophthalmology studies. Additionally, WCCT’s vast site network allows Sponsors to move seamlessly from Phase 1 to Phase 2.

Strategically Delivered Clinical Services

WCCT is committed to serving as an end-to-end solution for early clinical development. Therefore, we have geared all of our personnel, processes, partnerships, and vendors to suit the specific needs of early phase clinical trials:

  • Regulatory expertise for complex and specialty trial designs
  • Project Managers with extensive background in Phase 1 trials
  • Safety Reference Laboratory with 24/7 availability
  • Dedicated Recruitment Department with proven retention programs

Submit RFI/RFP

Tell us about your study to receive a customized proposal. Simply fill out the form below and submit your RFI/RFP.

Request for Information and Proposal (RFI/RFP)

* This form does not support Internet Explorer. If you are using Internet Explorer, please try from another browser.

WCCT News - Clinical Research News and Developments

WCCT News

Stay up-to-date on clinical research news and developments.

Careers at WCCT Phase 1 Unit for Clinical Trials

Careers

Careers that put you at the forefront of medical breakthroughs.

WCCT Blog - Clinical Trials & Pharmacology & Extended Clinical Services

Blog

The blog delivers industry-related developments and announcements regarding expanded clinical services.

Start typing and press Enter to search